In just three months, Phlow and Enveda generated and analyzed nearly 20,000 unique reactions, creating one of the largest high-quality datasets of its kind. The resulting uniform dataset is ...

Operating under the FDA's 503B pathway, the Apex facility will prioritize the production of generic shortage-listed ...

The engagement will explore the use of cellular fermentation to make key starting materials required for pharmaceutical ...

Successful completion of the first large-scale manufacture of narmafotinib which produced approx. 13 kg of drugSuccessful transition of process ...

USP is developing digital reference standards to integrate into modern digital environments, enhancing regulatory confidence ...

Scheduled for August 2025 completion, the initial $2-billion phase included construction of a 1-million-sq-ft complex with two drug substance manufacturing buildings, each containing four 20,000-liter ...

VILNIUS, LT / ACCESS Newswire / July 29, 2025 / Diorasis Therapeutics (“DTx”), a preclinical-stage biotechnology company developing gene therapies for ophthalmic diseases, has entered into a strategic ...

Blau Farmacêutica, a Brazilian pharmaceutical company listed on Brazilian Stock Market (B3) and a regional leader in hospital pharmaceuticals with a strong presence across Latin America, announces an ...

China quietly became biotech’s back-office, from molecule synthesis and clinical trials to novel drug licensing. Now the ...